Contact Us

Your research and discovery partner

Find the molecules that matter to you

Every day matters when it comes to building the next successful mRNA-based therapeutic or vaccine. Getting to market faster can make all the difference for patients in need. Start with the right foundation so you can secure funding, meet timelines, beat competitors, and, most importantly—improve patients’ lives.

As a legacy innovator in nucleic acid synthesis, TriLink leverages over 20 years of experience to help our partners discover and target high-potential lead construct candidates. We provide personalized support throughout every step of the R&D process, with state-of-the-art products bolstered by extensive CDMO services that set you up for success.

Common obstacles during discovery include identifying and purifying target plasmids, scaling up efficiently, and reducing risk and costs associated with discovery. Our optimization solutions include plasmid manufacturing services, analytical services, and more to help mitigate these challenges.

Diverse product offerings ensure the highest quality

Starting with high-quality materials can set you up for high-quality discoveries. We are a leading provider of raw materials used in the manufacture of mRNA, offering nucleic acid products like catalog mRNA, modified nucleoside triphosphates, and mRNA capping analogs, including our proprietary CleanCap® reagents.


Dedicated mRNA CDMO services set you up for success from the start

Discovery phase mRNA CDMO services include custom mRNA synthesis, custom oligonucleotide synthesis, and other custom chemistry solutions, along with a complete portfolio of analytical services. By starting with a partner equipped for the early stages of development, you can avoid the inconsistency and inconvenience of working with multiple vendors.

Expert guidance empowers your research

As a trusted leader in nucleic acid synthesis and manufacturing since its inception in 1996, we draw on a legacy of expertise to support your projects at every step and through the finish line. Leverage our highly experienced team so you can get it right, right out of the gate.


Our services

Our extensive service offerings continue well past the discovery phase. Learn more about pre-clinical, clinical, and commercial development capabilities.

Our products

Our quality mRNA products, including modified NTPs and CleanCap reagents, maximize efficiency and accelerate research. Browse our catalog of industry-leading products or learn more about custom options.